AT297902T - Sulfonyl pyridazinone derivatives for use as aldose reductase inhibitors - Google Patents

Sulfonyl pyridazinone derivatives for use as aldose reductase inhibitors

Info

Publication number
AT297902T
AT297902T AT02251173T AT02251173T AT297902T AT 297902 T AT297902 T AT 297902T AT 02251173 T AT02251173 T AT 02251173T AT 02251173 T AT02251173 T AT 02251173T AT 297902 T AT297902 T AT 297902T
Authority
AT
Austria
Prior art keywords
use
reductase inhibitors
aldose reductase
pyridazinone derivatives
sulfonyl pyridazinone
Prior art date
Application number
AT02251173T
Other languages
German (de)
Inventor
William Holt Martin
Banavara L Mylari
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US27225401P priority Critical
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AT297902T publication Critical patent/AT297902T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/18Sulfur atoms
AT02251173T 2001-02-28 2002-02-20 Sulfonyl pyridazinone derivatives for use as aldose reductase inhibitors AT297902T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US27225401P true 2001-02-28 2001-02-28

Publications (1)

Publication Number Publication Date
AT297902T true AT297902T (en) 2005-07-15

Family

ID=23039045

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02251173T AT297902T (en) 2001-02-28 2002-02-20 Sulfonyl pyridazinone derivatives for use as aldose reductase inhibitors

Country Status (9)

Country Link
US (1) US6730674B2 (en)
EP (1) EP1236720B1 (en)
JP (1) JP2003128657A (en)
AT (1) AT297902T (en)
BR (1) BR0200536A (en)
CA (1) CA2373395C (en)
DE (1) DE60204611T2 (en)
ES (1) ES2240657T3 (en)
MX (1) MXPA02002252A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934061B3 (en) 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba and its derivatives for the treatment of pain
EP1392310A1 (en) * 2001-04-30 2004-03-03 Pfizer Products Inc. Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
AU761191B2 (en) 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
AU2005249794A1 (en) 2004-06-04 2005-12-15 Teva Pharmaceutical Industries, Ltd. Pharmaceutical composition containing irbesartan
BRPI0613754A2 (en) * 2005-07-21 2011-02-08 Hoffmann La Roche compounds, ester of a compound, pharmaceutical compositions comprising the compound, a method for the therapeutic and / or prophylactic treatment of diseases which are modulated by thyroid hormÈnio use of the compounds and analogs
JP2010043063A (en) 2008-05-09 2010-02-25 Agency For Science Technology & Research Diagnosis and treatment of kawasaki disease
GB0907601D0 (en) * 2009-05-01 2009-06-10 Equateq Ltd Novel methods
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE574204A (en) * 1958-12-24 1959-06-24 Henri Morren Drifts of sulfonyl pyridazine
IE47592B1 (en) 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4939140A (en) 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
US4996204A (en) 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
FR2647676A1 (en) 1989-06-05 1990-12-07 Union Pharma Scient Appl New pyridazinone derivatives, processes for preparing them and medicaments containing them which are useful, in particular, as aldose reductase inhibitors
CZ387092A3 (en) * 1991-03-28 1994-02-16 Pfizer Pyridazinoacetic acids, their derivatives, process of their preparation and use
TWI238064B (en) 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
WO2002079198A1 (en) * 2001-03-30 2002-10-10 Pfizer Products Inc. Pyridazinone aldose reductase inhibitors
AU761191B2 (en) * 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia

Also Published As

Publication number Publication date
US20030004139A1 (en) 2003-01-02
JP2003128657A (en) 2003-05-08
BR0200536A (en) 2003-04-29
EP1236720A1 (en) 2002-09-04
ES2240657T3 (en) 2005-10-16
EP1236720B1 (en) 2005-06-15
CA2373395A1 (en) 2002-08-28
US6730674B2 (en) 2004-05-04
CA2373395C (en) 2006-01-10
DE60204611T2 (en) 2006-05-11
MXPA02002252A (en) 2002-09-30
DE60204611D1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
DE60325761D1 (en) derivatives Diaminotriazole and their use as protein kinase inhibitors
DE60205727D1 (en) Piperazine and piperidine derivatives as agonists of the melanocortin receptor
DE602006009303D1 (en) System for tracking of strahlungsablationen
DE60329910D1 (en) benzazoles substituted and their use as raf kinase inhibitors
DE60231407D1 (en) Inhibitory antibody of HER3 activity
NO20044374L (en) pyrimidine
DE60330227D1 (en) N3-alkylated benzimidazole derivatives as inhibitors mek
DE60214703D1 (en) Thiazole compounds which are useful as inhibitors of protein kinases
DE60234125D1 (en) inhibitors e
RU2004136977A (en) Derivatives pyridazin-3 (2h) -one as phosphodiesterase 4 inhibitors (pde4)
DE602005025733D1 (en) Pyrazolopyrimidinderivate as inhibitors of cyclin-dependent kinase
DE60103935D1 (en) Imidazol-5-yl-2-anilino-pyrimidines as inhibitors of cell proliferation
DE60315355D1 (en) Piperidinyl-thiazole-carboxylic acid derivatives as angiogenesis inhibitors
DE60316012D1 (en) Purine derivatives and their use as ligands of the cannabinoid receptor
DE60235617D1 (en) Arly and diaryl piperidine derivatives useful as mch-inhibitors
AT319137T (en) amplifier modulation
AT402174T (en) Imidazopyridine derivatives as kinase inhibitors
AT477251T (en) Pyrrole inhibitors as glycogen synthase kinase 3
AT437872T (en) Protein kinase inhibitors
AT374181T (en) Fluorpyrrolidine as dipeptidylpeptidaseinhibitoren
AT463486T (en) Enantiopure aminoheteroaryl-compounds as protein kinase inhibitors
AT498613T (en) Quinazolinone derivatives as PARP inhibitors
DE60314427D1 (en) Pyrazolopyrimidine as inhibitors of cyclin-dependent kinases-
PT1362050E (en) pyrimidine derivatives for inhibition of cell proliferation
DE60112312D1 (en) Imidazole derivatives as raf kinase inhibitors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties